Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04042259 · ClinicalTrials.gov registry record · NA

Delayed Primary Closure Using Negative Pressure Wound Therapy

A NA study of Infection Abdominal, sponsored by Medical College of Wisconsin.

Recruiting
Registry status
NA
Development phase
350
Enrollment target
1
Study location

NCT04042259: Recruiting NA study of Infection Abdominal, sponsored by Medical College of Wisconsin.

NCT04042259 is a NA study of Infection Abdominal that is actively recruiting participants, run by Medical College of Wisconsin. The registered enrollment target is 350 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04042259, a NA study of Infection Abdominal, is actively recruiting participants, sponsored by Medical College of Wisconsin.

RECRUITING
Registry status
NA
Development phase
350 participants
Enrollment target
1
Study location

Study Summary

Surgical site infection rates for contaminated or dirty laparotomy wounds can be as high as 45%. Surgical management of dirty and contaminated wounds has been controversial in the literature and between surgeons. Primary closure (PC) of these wounds can lead to multiple complications including surgical site infection (SSI), necrotizing soft tissue infection, wound and fascial dehiscence, evisceration, sepsis and hernia development. However, an alternative technique of utilizing secondary intention results in prolonged healing time and increased cost and healthcare resource utilization. Delayed primary closure (DPC) was developed to address many of these issues. Bhangu completed a systematic review and meta-analysis comparing primary versus delayed primary skin closure in contaminated and dirty abdominal wounds. They included 8 studies randomizing 623 patients with contaminated or dirty abdominal wounds to either DPC or PC. The most common diagnosis was appendicitis (77.4%), followed by perforated abdominal viscus (11.5%), ileostomy closure (6.5%), trauma (2.7%), and intra-abdominal abscess/other peritonitis (1.9%). The time to first assessment for DPC was between 2 and 5 days postoperatively. In all studies, the DPC group had significantly less SSIs using a fixed-effect model (odds ratio, 0.65; 95%CI, 0.40-0.93; P = .02). However, heterogeneity was high (72%), and using a random-effects model, the effect was no longer significant (odds ratio, 0.65; 95% CI, 0.25-1.64; P = .36). Additionally, all of the studies were found to be at high risk of bias, with marked deficiencies in study design and outcome assessment. A recent systematic review showed improved fascial closure rates with negative pressure wound therapy (NPWT) Yet, a large national study using NPWT to perform a DPC has been shown to actually decrease the rate of closure. Access to NPWT has increased over the years and innovative wound management techniques including incisional application of negative pressu

Primary Outcome

Wound infection, dehiscence, evisceration

Conditions Studied

Interventions

  • DEVICE Abthera
  • PROCEDURE Open adbdomen for post-laparotomy without NPWT device

Study Locations (1)

Wisconsin

  • Froedtert Hospital - Milwaukee

Trial Details

FieldValue
Enrollment Target 350 participants
Start Date 2020-08-03
Est. Completion 2025-12
Phase NA
Medical College of Wisconsin

447 total trials

What NCT04042259 shows while recruiting

NCT04042259 is an interventional study that assigns participants to a tested intervention. The registered 350 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (75% lower).

The record links to 1 condition, with Infection Abdominal appearing as the primary indexed condition, and to 2 interventions - of which Abthera is the first listed.

NCT04042259 reports a single indexed study location in Wisconsin.

Frequently Asked Questions

What is clinical trial NCT04042259 about?

NCT04042259 is a clinical study titled "Delayed Primary Closure Using Negative Pressure Wound Therapy". Surgical site infection rates for contaminated or dirty laparotomy wounds can be as high as 45%. Surgical management of dirty and contaminated wounds has been controversial in the literature and between surgeons. Primary closure (PC) of these wounds can lead to multiple complications including surgi...

What is the current status of trial NCT04042259?

This trial is currently recruiting. It is a NA study. The enrollment target is 350 participants. The study started on 2020-08-03. Estimated completion is 2025-12.

What conditions does trial NCT04042259 study?

This clinical trial studies the following conditions: Infection Abdominal.

What interventions are being tested in trial NCT04042259?

The interventions under investigation include: Abthera (DEVICE), Open adbdomen for post-laparotomy without NPWT device (PROCEDURE).

Who is sponsoring clinical trial NCT04042259?

This trial is sponsored by Medical College of Wisconsin, which has 447 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04042259 being conducted?

This trial has 1 study location across Wisconsin. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

How this trial's enrollment target compares

Where NCT04042259's enrollment target sits among peer trials

350 292nd of 2000 higher than 1,700 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00900575 · 350 participants · NA

    Cervical Cancer Detection Using Optical Spectroscopy

  • NCT01627821 · 350 participants · NA

    Evaluation of the Jarvik 2000 Left Ventricular Assist System With Post-Auricular Connector--Destination Therapy Study

  • NCT02357654 · 350 participants · Phase 4

    GnRH for Luteal Support in IVF/ICSI/FET Cycles

  • NCT03997370 · 350 participants · Phase 1

    Evaluation of Dosing Procedures of Chemotherapy Treatment (Carboplatin) With the Contrast Agent Iohexol

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT04042259, the US trial registry maintained by the National Library of Medicine. NCT04042259 (mid enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.